ERBB2 and breast carcinoma: Sonju et al. (2022) constructed a pH-sensitive liposomal formulation containing a peptidomimetic-Dox conjugate (PS5-Dox-L) targeting human epidermal growth factor receptor-2 (HER2)-positive lung and breast cancer cells.